{"id":"NCT02421588","sponsor":"PharmaMar","briefTitle":"Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients","officialTitle":"Phase III Randomized Clinical Trial of Lurbinectedin (PM01183) Versus Pegylated Liposomal Doxorubicin or Topotecan in Patients With Platinum-resistant Ovarian Cancer (CORAIL Trial)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-05","primaryCompletion":"2018-10-12","completion":"2018-10-12","firstPosted":"2015-04-20","resultsPosted":"2020-03-05","lastUpdate":"2020-04-03"},"enrollment":442,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Ovarian Cancer"],"interventions":[{"type":"DRUG","name":"Lurbinectedin (PM01183)","otherNames":[]},{"type":"DRUG","name":"Pegylated liposomal doxorubicin (PLD)","otherNames":[]},{"type":"DRUG","name":"Topotecan","otherNames":[]}],"arms":[{"label":"Arm A","type":"EXPERIMENTAL"},{"label":"Arm B","type":"ACTIVE_COMPARATOR"}],"summary":"Multicenter, open-label, randomized, controlled phase III clinical trial to evaluate the activity and safety of PM01183 versus PLD or topotecan as control arm in patients with platinum-resistant ovarian cancer. PM01183 will be explored as single agent in the experimental arm (Arm A) versus PLD or topotecan in the control arm (Arm B).","primaryOutcome":{"measure":"Progression-free Survival by Independent Review Committee","timeFrame":"Time from the date of randomization to the date of PD, death (of any cause), or last tumor evaluation, whichever came first, assessed up to 3 years","effectByArm":[{"arm":"Lurbinectedin","deltaMin":3.5,"sd":null},{"arm":"Control (PLD or Topotecan)","deltaMin":3.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6294"},{"comp":"OG000","p":null},{"comp":"OG001","p":null},{"comp":"OG000 vs OG001","p":"0.5032"},{"comp":"OG000","p":null},{"comp":"OG001","p":null},{"comp":"OG000 vs OG001","p":"0.6742"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":3},"locations":{"siteCount":28,"countries":["United States"]},"refs":{"pmids":["37407274","34521554"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":92,"n":219},"commonTop":["Nausea","Fatigue","Neutropenia","Vomiting","Anaemia"]}}